This fully human anti-CD20 monoclonal antibody has excellent affinity and specificity, and a significant cytotoxic effect on lymphoma cells, and so can be used for the preparation of pharmaceutical compositions for treating or diagnosing diseases such as non-Hodgkin lymphoma, B cell lymphoma, rheumatic and rheumatoid diseases, systemic lupus erythematosus, immune thrombocytopenic purpura and multiple sclerosis.
Figure 1 The results of CDC test of Raji cells.
The purification of human antibodies H2L3, H2L6, H2L10, H8L3 by CHO cells after affinity maturation. And CDC functional screening of H8L10;
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
For Research Use Only. Not For Clinical Use.